LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

STERIS PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

252.04 2.45

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

243.99

Max

252.11

Pagrindiniai rodikliai

By Trading Economics

Pajamos

16M

173M

Pardavimai

42M

1.4B

P/E

Sektoriaus vid.

37.416

56.602

Pelnas, tenkantis vienai akcijai

2.32

Dividendų pajamingumas

1.01

Pelno marža

12.643

Darbuotojai

18,000

EBITDA

44M

374M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+4.81% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.01%

2.45%

Kitas uždarbis

2025-08-05

Kitas dividendų mokėjimo data

2025-06-26

Kita Ex Dividend data

2025-06-10

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

23B

Ankstesnė atidarymo kaina

249.59

Ankstesnė uždarymo kaina

252.04

Naujienos nuotaikos

By Acuity

50%

50%

177 / 382 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

STERIS PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-14 20:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

2025-05-14 20:30; UTC

Uždarbis

Steris 4Q Rev $1.5B >STE

2025-05-14 20:30; UTC

Uždarbis

Steris 4Q Adj EPS $2.74 >STE

2025-02-05 21:35; UTC

Uždarbis

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

2025-02-05 21:34; UTC

Uždarbis

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

2025-02-05 21:34; UTC

Uždarbis

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

2025-02-05 21:33; UTC

Uždarbis

Steris 3Q EPS $1.75 >STE

2025-02-05 21:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

2025-02-05 21:30; UTC

Uždarbis

Steris 3Q Rev $1.4B >STE

2025-02-05 21:30; UTC

Uždarbis

Steris 3Q Adj EPS $2.32 >STE

2024-11-06 21:41; UTC

Uždarbis

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

2024-11-06 21:40; UTC

Uždarbis

Steris 2Q EPS $1.51 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris 2Q Adj EPS $2.14 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris 2Q Rev $1.3B >STE

2024-08-06 20:36; UTC

Uždarbis

Steris 1Q Adj EPS $2.03 >STE

2024-08-06 20:30; UTC

Uždarbis

Steris 1Q Net $139.9M >STE

2024-08-06 20:30; UTC

Uždarbis

Steris 1Q EPS $1.41 >STE

2024-08-06 20:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

2024-06-03 11:03; UTC

Įsigijimai, susijungimai, perėmimai

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

2024-05-31 20:47; UTC

Įsigijimai, susijungimai, perėmimai

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

Akcijų palyginimas

Kainos pokytis

STERIS PLC Prognozė

Kainos tikslas

By TipRanks

4.81% į viršų

12 mėnesių prognozė

Vidutinis 258.75 USD  4.81%

Aukščiausias 280 USD

Žemiausias 240 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines STERIS PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

3

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

225 / 226.35Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Rinkos nuotaikos

By Acuity

177 / 382 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.